| Year |
Citation |
Score |
| 2022 |
Ivanick NM, Oakley ER, Kunadharaju R, Brackett C, Bellnier DA, Tworek LM, Kurenov SN, Gollnick SO, Hutson AD, Busch TM, Shafirstein G. First-In-Human Computer-Optimized Endobronchial Ultrasound-Guided Interstitial Photodynamic Therapy for Patients With Extrabronchial or Endobronchial Obstructing Malignancies. Jto Clinical and Research Reports. 3: 100372. PMID 36188632 DOI: 10.1016/j.jtocrr.2022.100372 |
0.731 |
|
| 2022 |
Falk-Mahapatra R, Gollnick SO. Photodynamic Therapy-Induced Cyclooxygenase 2 Expression in Tumor-Draining Lymph Nodes Regulates B-Cell Expression of Interleukin 17 and Neutrophil Infiltration. Photochemistry and Photobiology. PMID 35103990 DOI: 10.1111/php.13601 |
0.352 |
|
| 2020 |
Consiglio CR, Udartseva O, Ramsey KD, Bush C, Gollnick SO. Enzalutamide, an androgen receptor antagonist, enhances myeloid cell-mediated immune suppression and tumor progression. Cancer Immunology Research. PMID 32661092 DOI: 10.1158/2326-6066.Cir-19-0371 |
0.514 |
|
| 2020 |
Falk-Mahapatra R, Gollnick SO. Photodynamic Therapy and Immunity: An Update. Photochemistry and Photobiology. PMID 32128821 DOI: 10.1111/Php.13253 |
0.507 |
|
| 2019 |
Ito F, Vardam TD, Appenheimer MM, Eng KH, Gollnick SO, Muhitch JB, Evans SS. thermal ablation augments antitumor efficacy of adoptive T cell therapy. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 36: 22-36. PMID 31795828 DOI: 10.1080/02656736.2019.1653500 |
0.544 |
|
| 2019 |
Udartseva OO, Zhidkova OV, Ezdakova MI, Ogneva IV, Andreeva ER, Buravkova LB, Gollnick SO. Low-dose photodynamic therapy promotes angiogenic potential and increases immunogenicity of human mesenchymal stromal cells. Journal of Photochemistry and Photobiology. B, Biology. 199: 111596. PMID 31450129 DOI: 10.1016/j.jphotobiol.2019.111596 |
0.42 |
|
| 2018 |
Sass SN, Ramsey KD, Egan SM, Wang J, Cortes Gomez E, Gollnick SO. Tumor-associated myeloid cells promote tumorigenesis of non-tumorigenic human and murine prostatic epithelial cell lines. Cancer Immunology, Immunotherapy : Cii. PMID 29502208 DOI: 10.1007/S00262-018-2143-Y |
0.411 |
|
| 2017 |
Egan SM, Karasik E, Ellis L, Gollnick SO. miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth. Oncotarget. 8: 67626-67638. PMID 28978058 DOI: 10.18632/Oncotarget.18795 |
0.308 |
|
| 2017 |
Gollnick S. Enhancement of anti-tumor immunity by PDT: Mechanisms and exploitation Photodiagnosis and Photodynamic Therapy. 17: A31. DOI: 10.1016/j.pdpdt.2017.01.070 |
0.432 |
|
| 2016 |
Brackett CM, Kojouharov B, Veith J, Greene KF, Burdelya LG, Gollnick SO, Abrams SI, Gudkov AV. Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis. Proceedings of the National Academy of Sciences of the United States of America. PMID 26831100 DOI: 10.1073/Pnas.1521359113 |
0.79 |
|
| 2016 |
Brackett C, Kojouharov B, Gollnick S, Gudkov A, Burdelya L. Abstract B090: A Toll-like receptor 5 agonist entolimod as a potential anticancer immunotherapeutic agent Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B090 |
0.79 |
|
| 2015 |
Shafirstein G, Battoo A, Harris KE, Baumann H, Gollnick SO, Lindenmann J, Nwogu CE. Photodynamic Therapy of Non-Small Cell Lung Cancer: Narrative Review and Future Directions. Annals of the American Thoracic Society. PMID 26646726 DOI: 10.1513/Annalsats.201509-650Fr |
0.369 |
|
| 2015 |
Ito F, Ku AW, Bucsek MJ, Muhitch JB, Vardam-Kaur T, Kim M, Fisher DT, Camoriano M, Khoury T, Skitzki JJ, Gollnick SO, Evans SS. Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer. Plos One. 10: e0143370. PMID 26599402 DOI: 10.1371/Journal.Pone.0143370 |
0.362 |
|
| 2015 |
Shams M, Owczarczak B, Manderscheid-Kern P, Bellnier DA, Gollnick SO. Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease. Cancer Immunology, Immunotherapy : Cii. 64: 287-97. PMID 25384911 DOI: 10.1007/S00262-014-1633-9 |
0.58 |
|
| 2015 |
Bakhribah H, Dy GK, Ma WW, Zhao Y, Opyrchal M, Purmal A, Gollnick S, Brady WE, Fetterly GJ, Ngamphaiboon N, Reungwetwattana T, Jacob SM, O'Hara C, Siedlecki F, Adjei A, et al. A phase I study of the toll-like receptor 5 (TLR5) agonist, entolimod in patients (pts) with advanced cancers. Journal of Clinical Oncology. 33: 3063-3063. DOI: 10.1200/Jco.2015.33.15_Suppl.3063 |
0.326 |
|
| 2013 |
Brackett CM, Muhitch JB, Evans SS, Gollnick SO. IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation. Journal of Immunology (Baltimore, Md. : 1950). 191: 4348-57. PMID 24026079 DOI: 10.4049/Jimmunol.1103621 |
0.734 |
|
| 2013 |
Dayanc BE, Bansal S, Gure AO, Gollnick SO, Repasky EA. Enhanced sensitivity of colon tumour cells to natural killer cell cytotoxicity after mild thermal stress is regulated through HSF1-mediated expression of MICA. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 29: 480-90. PMID 23902341 DOI: 10.3109/02656736.2013.821526 |
0.343 |
|
| 2012 |
Riddell JR, Maier P, Sass SN, Moser MT, Foster BA, Gollnick SO. Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α. Plos One. 7: e50394. PMID 23185615 DOI: 10.1371/Journal.Pone.0050394 |
0.773 |
|
| 2012 |
Gollnick SO. Photodynamic therapy and antitumor immunity. Journal of the National Comprehensive Cancer Network : Jnccn. 10: S40-3. PMID 23055214 |
0.338 |
|
| 2012 |
Belicha-Villanueva A, Riddell J, Bangia N, Gollnick SO. The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules. Lasers in Surgery and Medicine. 44: 60-8. PMID 22246985 DOI: 10.1002/Lsm.21160 |
0.787 |
|
| 2011 |
Brackett CM, Owczarczak B, Ramsey K, Maier PG, Gollnick SO. IL-6 potentiates tumor resistance to photodynamic therapy (PDT). Lasers in Surgery and Medicine. 43: 676-85. PMID 22057495 DOI: 10.1002/Lsm.21107 |
0.789 |
|
| 2011 |
Fisher DT, Chen Q, Skitzki JJ, Muhitch JB, Zhou L, Appenheimer MM, Vardam TD, Weis EL, Passanese J, Wang WC, Gollnick SO, Dewhirst MW, Rose-John S, Repasky EA, Baumann H, et al. IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. The Journal of Clinical Investigation. 121: 3846-59. PMID 21926464 DOI: 10.1172/Jci44952 |
0.544 |
|
| 2011 |
Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, et al. Photodynamic therapy of cancer: an update. Ca: a Cancer Journal For Clinicians. 61: 250-81. PMID 21617154 DOI: 10.3322/Caac.20114 |
0.463 |
|
| 2011 |
Riddell JR, Bshara W, Moser MT, Spernyak JA, Foster BA, Gollnick SO. Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature. Cancer Research. 71: 1637-46. PMID 21343392 DOI: 10.1158/0008-5472.Can-10-3674 |
0.779 |
|
| 2011 |
Brackett CM, Gollnick SO. Photodynamic therapy enhancement of anti-tumor immunity. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 10: 649-52. PMID 21253659 DOI: 10.1039/C0Pp00354A |
0.794 |
|
| 2010 |
Belicha-Villanueva A, Golding M, McEvoy S, Sarvaiya N, Cresswell P, Gollnick SO, Bangia N. Identification of an alternate splice form of tapasin in human melanoma Human Immunology. 71: 1018-1026. PMID 20600451 DOI: 10.1016/J.Humimm.2010.05.019 |
0.315 |
|
| 2010 |
Riddell JR, Wang XY, Minderman H, Gollnick SO. Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4. Journal of Immunology (Baltimore, Md. : 1950). 184: 1022-30. PMID 20018613 DOI: 10.4049/Jimmunol.0901945 |
0.778 |
|
| 2010 |
Gollnick SO, Brackett CM. Enhancement of anti-tumor immunity by photodynamic therapy. Immunologic Research. 46: 216-26. PMID 19763892 DOI: 10.1007/S12026-009-8119-4 |
0.801 |
|
| 2009 |
Kabingu E, Oseroff AR, Wilding GE, Gollnick SO. Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4460-6. PMID 19549769 DOI: 10.1158/1078-0432.Ccr-09-0400 |
0.798 |
|
| 2008 |
Bernstein ZP, Dougherty T, Gollnick S, Schwartz SA, Mahajan SD, Kepner J, Sumlin A, Stewart C, Wallace P, Adal A, Walder H, Poiesz B. Photopheresis in HIV-1 infected patients utilizing benzoporphyrin derivative (BPD) verteporfin and light. Current Hiv Research. 6: 152-63. PMID 18336263 DOI: 10.2174/157016208783885001 |
0.32 |
|
| 2007 |
Kousis PC, Henderson BW, Maier PG, Gollnick SO. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Research. 67: 10501-10. PMID 17974994 DOI: 10.1158/0008-5472.Can-07-1778 |
0.821 |
|
| 2007 |
Kabingu E, Vaughan L, Owczarczak B, Ramsey KD, Gollnick SO. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells British Journal of Cancer. 96: 1839-1848. PMID 17505510 DOI: 10.1038/Sj.Bjc.6603792 |
0.764 |
|
| 2007 |
Bernstein ZP, Dougherty T, Gollnick S, Schwartz S, Mahajan S, Kepner J, Sumlin A, Stewart C, Wallace P, Walder H, Poiesz B. Photopheresis in HIV-1 Infected Patients Utilizing (Benzoporphyrin Derivative Verteporfin/BPD-MA) and Light. Blood. 110: 2275-2275. DOI: 10.1182/Blood.V110.11.2275.2275 |
0.321 |
|
| 2006 |
Gollnick SO, Owczarczak B, Maier P. Photodynamic therapy and anti-tumor immunity. Lasers in Surgery and Medicine. 38: 509-15. PMID 16788921 DOI: 10.1002/Lsm.20362 |
0.597 |
|
| 2006 |
Bernstein ZP, Dougherty T, Schwartz S, Gollnick S, Stewart C, Walder H, Nair M, Mahajan S, Sumlin A, Poiesz B. Photopheresis in HIV-1 Infected Patients (Pt) Using Benzoporphyrin Derivative (BPD-MA) Induces Apoptosis in CD4 Cells, Increases Cytolytic T-Cell Activity, Intracellular Expression of Chemokines, and Decreases HIV Infectivity and Viral Load. Blood. 108: 1257-1257. DOI: 10.1182/Blood.V108.11.1257.1257 |
0.377 |
|
| 2006 |
Gollnick SO, Owczarczak B, Maier P. Induction of anti-tumor immunity by photodynamic therapy (PDT) Proceedings of Spie - the International Society For Optical Engineering. 6087. DOI: 10.1117/12.649852 |
0.584 |
|
| 2004 |
Henderson BW, Gollnick SO, Snyder JW, Busch TM, Kousis PC, Cheney RT, Morgan J. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Research. 64: 2120-6. PMID 15026352 DOI: 10.1158/0008-5472.Can-03-3513 |
0.787 |
|
| 2004 |
Bernstein ZP, Dougherty T, Schwartz SA, Gollnick S, Stewart C, Walder H, Nair MP, Mahajan SD, Sumlin A, Poiesz BJ. Photopheresis in HIV-1 Infected Patients (pt) using Benzoporphyrin Derivative (BPD-MA) Induces Apoptosis in CD4 Cells, Increases Intracellular Expression of Chemokines and Decreases HIV Infectivity and Viral Load. Blood. 104: 3836-3836. DOI: 10.1182/Blood.V104.11.3836.3836 |
0.356 |
|
| 2004 |
Gollnick SO, Kabingu E, Kousis PC, Henderson BW. Stimulation of the host immune response by photodynamic therapy (PDT) Proceedings of Spie - the International Society For Optical Engineering. 5319: 60-70. DOI: 10.1117/12.530437 |
0.76 |
|
| 2003 |
Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. Cancer Research. 63: 7584-90. PMID 14633671 |
0.387 |
|
| 2003 |
Gollnick SO, Evans SS, Baumann H, Owczarczak B, Maier P, Vaughan L, Wang WC, Unger E, Henderson BW. Role of cytokines in photodynamic therapy-induced local and systemic inflammation British Journal of Cancer. 88: 1772-1779. PMID 12771994 DOI: 10.1038/Sj.Bjc.6600864 |
0.417 |
|
| 2002 |
Bernstein ZP, Brooks SP, Chanan-Khan A, Gollnick SO, Gilbert MJ, Miller KC, Tomasi TB. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores allostimulatory function to accessory cells in patients with AIDS. Hiv Clinical Trials. 3: 219-24. PMID 12032880 DOI: 10.1310/Hp8B-Nf27-Vfwa-80Yx |
0.326 |
|
| 2002 |
Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Research. 62: 1604-8. PMID 11912128 |
0.398 |
|
| 2001 |
Gollnick SO, Musser DA, Oseroff AR, Vaughan L, Owczarczka B, Henderson BW. IL-10 does not play a role in cutaneous photofrin® photodynamic therapy-induced suppression of the contact hypersensitivity response Photochemistry and Photobiology. 74: 811-816. PMID 11783937 DOI: 10.1562/0031-8655(2001)074<0811:Idnpar>2.0.Co;2 |
0.344 |
|
| 2001 |
Gollnick SO, Lee BY, Vaughan L, Owczarczak B, Henderson BW. Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytes Photochemistry and Photobiology. 73: 170-177. PMID 11272731 DOI: 10.1562/0031-8655(2001)073<0170:Aotigp>2.0.Co;2 |
0.351 |
|
| 2001 |
Gollnick SO, Mazzacua A, Vaughan L, Owczarczak B, Maier P, Henderson BW. Photodynamic therapy (PDT) treatment enhances tumor cell antigenicity Proceedings of Spie - the International Society For Optical Engineering. 4257: 25-28. DOI: 10.1117/12.434725 |
0.505 |
|
| 2000 |
Leonard KA, Hall JP, Nelen MI, Davies SR, Gollnick SO, Camacho S, Oseroff AR, Gibson SL, Hilf R, Detty MR. A selenopyrylium photosensitizer for photodynamic therapy related in structure to the antitumor agent AA1 with potent in vivo activity and no long-term skin photosensitization. Journal of Medicinal Chemistry. 43: 4488-98. PMID 11087573 DOI: 10.1021/Jm000154P |
0.35 |
|
| 2000 |
Stilts CE, Nelen MI, Hilmey DG, Davies SR, Gollnick SO, Oseroff AR, Gibson SL, Hilf R, Detty MR. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. Journal of Medicinal Chemistry. 43: 2403-10. PMID 10882367 DOI: 10.1021/Jm000044I |
0.36 |
|
| 1998 |
Gollnick SO, Musser DA, Henderson BW. Photodynamic therapy affects the expression of IL-6 and IL-10 in vivo Proceedings of Spie - the International Society For Optical Engineering. 3254: 19-26. DOI: 10.1117/12.308168 |
0.343 |
|
| 1997 |
Gollnick SO, Liu X, Owczarczak B, Musser DA, Henderson BW. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo Cancer Research. 57: 3904-3909. PMID 9307269 |
0.309 |
|
| 1997 |
Murphy SP, Gollnick SO, Pazmany T, Maier P, Elkin G, Tomasi TB. Repression of MHC class II gene transcription in trophoblast cells by novel single-stranded DNA binding proteins Molecular Reproduction and Development. 47: 390-403. PMID 9211423 DOI: 10.1002/(Sici)1098-2795(199708)47:4<390::Aid-Mrd5>3.0.Co;2-F |
0.315 |
|
| 1995 |
Gollnick SO, Cheng HL, Grande CC, Thompson D, Tomasi TB. Effects of transforming growth factor-β on bone marrow macrophage Ia expression induced by cytokines Journal of Interferon and Cytokine Research. 15: 485-491. PMID 7648451 DOI: 10.1089/Jir.1995.15.485 |
0.352 |
|
| 1993 |
Evans SS, Collea RP, Appenheimer MM, Gollnick SO. Interferon-α induces the expression of the L-selectin homing receptor in human B lymphoid cells Journal of Cell Biology. 123: 1889-1898. PMID 7506267 DOI: 10.1083/Jcb.123.6.1889 |
0.344 |
|
| 1987 |
Hudak SA, Gollnick SO, Conrad DH, Kehry MR. Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells Proceedings of the National Academy of Sciences of the United States of America. 84: 4606-4610. PMID 2955412 DOI: 10.1073/Pnas.84.13.4606 |
0.316 |
|
| Show low-probability matches. |